Emmanuel Mahé: Influence Statistics

Emmanuel Mahé

Emmanuel Mahé

Dermatology Department, Centre Hospitalier (CH), Argenteuil, France | Hôpital Victor Dupouy, Dermatologie, Argenteuil, France | Service de Dermatologie, Hôpital Victor Dupouy, ...

Emmanuel Mahé: Expert Impact

Concepts for which Emmanuel Mahé has direct influence: Children psoriasis , Onset psoriasis , Drug survival , Pyoderma gangrenosum , Psoriasis children , Psoriasis severity , Severe psoriasis .

Emmanuel Mahé: KOL impact

Concepts related to the work of other authors for which for which Emmanuel Mahé has influence: Atopic dermatitis , Skin cancer , Pediatric psoriasis , Drug reaction , Systemic symptoms , Psoriatic arthritis , Subcutaneous fat necrosis .

KOL Resume for Emmanuel Mahé


Dermatology Department, Centre Hospitalier (CH), Argenteuil, France


Service De Dermatologie Et Médecine Vasculaire, Hôpital Victor Dupouy, Argenteuil, France.

Department of Dermatology, Hospital of Argenteuil, Argenteuil, France


Service de dermatologie, hôpital Victor-Dupouy, 69, rue du Lieutenant-Colonel Prud’hon, 95100 Argenteuil, France

Dermatologie, Hôpital Victor Dupouy, Argenteuil

Groupe de Recherche de la Société Française de Dermatologie Pédiatrique, Paris


Service de Dermatologie, Hôpital Victor Dupouy, 69 rue du Lieutenant-Colonel Prud’hon, 95100, Argenteuil, France


Service de dermatologie et médecine vasculaire, hôpital Victor Dupouy, 69, rue du Lieutenant-Colonel Prud'hon, 95100 Argenteuil, France.

Department of Dermatology, Centre Hospitalier Argenteuil, Argenteuil, France


Dermatology Department, Hospital Victor Dupouy, Argenteuil, France

Dermatologie, centre hospitalier Argenteuil


Service de dermatologie, hôpital Victor-Dupouy, 69, rue du Lieutenant-Colonel-Prud’hon, 95107 Argenteuil, France


Service de Dermatologie, Hôpital Victor Dupouy, 69 rue du Lieutenant‐Colonel Prud'hon, 95100, Argenteuil, France

Dermatologie, Centre Hospitalier de Victor-Dupouy, Argenteuil


Service de dermatologie, hôpital Victor-Dupouy, 69, rue du Lieutenant-Colonel-Prudhon, 95100 Argenteuil, France. Electronic address:

Dermatologie, CHI d’Argenteuil, Argenteuil, France


Dermatologie, Centre Hospitalier Victor-Dupouy, Argenteuil, France


Department of Dermatology, Ambroise Paré University Hospital, University of Versailles‐Saint Quentin en Yvelines, Assistance Publique‐Hôpitaux de Paris, Boulogne‐Billancourt, France

Research Unit EA 4339 “Skin, cancer, and environment”


Dermatologie, hôpital Victor-Dupouy, Argenteuil, France

Research Unit EA 4339 ‘Skin, Cancer and Environment’

Prominent publications by Emmanuel Mahé

KOL-Index: 16304 . BACKGROUND: Scabies is a frequent condition seen in infants and children. Only topical treatments have been approved in infants, but some of them are poorly tolerated. Oral ivermectin is approved for the treatment of scabies in several countries, but its use in infants and children weighing < 15 kg is off label. OBJECTIVES: To assess the safety of ivermectin in infants and young children, ...
Known for Scabies Infants | Ivermectin Children | Oral Administration | Weighing 15
KOL-Index: 12310 . INTRODUCTION: Several studies have shown a high prevalence of cardiovascular and metabolic comorbidities in psoriasis. Our study aimed to evaluate the association of psoriasis with key comorbidities such as smoking, obesity, hypertension, dyslipidaemia and diabetes comparatively with French national data. MATERIAL AND METHODS: This multicentre noninterventional observational study of ...
Known for Psoriasis Patients | Prevalence Comorbidities | Obesity Hypertension | Age Onset
KOL-Index: 11861 . BACKGROUND: Few prospective studies are available on the incidence and analysis of the characteristics of adverse cutaneous drug reactions in hospital settings. OBJECTIVES: A 6-month prospective study was managed in our hospital among hospitalized patients to: (i) evaluate the incidence of cutaneous allergic reactions from systemic drugs; (ii) study characteristics of patients with ...
Known for Drug Reactions | Hospitalized Patients | Adverse Cutaneous | 15 Cases
KOL-Index: 10400 . BACKGROUND: Psoriasis is associated with higher prevalences of cardiovascular and metabolic comorbidities in adults but the relationship of age at onset and those prevalences is unknown. OBJECTIVE: To evaluate whether the childhood onset of psoriasis (COP) is correlated with the frequency of cardiovascular and metabolic comorbidities in adulthood. METHODS: This noninterventional, ...
Known for Onset Psoriasis | Metabolic Comorbidities | Dyslipidaemia Diabetes | Waist Circumference
KOL-Index: 9853 . BACKGROUND: Dupilumab is the first biologic available to treat atopic dermatitis (AD). Its effectiveness and safety were demonstrated in clinical trials. OBJECTIVE: We sought to assess the effectiveness and safety of dupilumab in adults with AD in a real-life French multicenter retrospective cohort. METHODS: We included patients treated during March 2017-April 2018. Efficacy outcomes, ...
Known for Atopic Dermatitis | Monoclonal Antibodies | Safety Dupilumab | Adult Cohort
KOL-Index: 9790 . BACKGROUND: Psoriasis is a T-cell-mediated immunological disease characterized by epidermal proliferation. The nature of the antigen(s) responsible for T-cell activation is still unknown. It has been suggested that the human papillomaviruses (HPVs) associated with epidermodysplasia verruciformis (EV), including the oncogenic HPV5, may contribute to the pathogenesis of ...
Known for Epidermodysplasia Verruciformis | Human Papillomaviruses | Atopic Dermatitis | Hpv5 Hpv36
KOL-Index: 9235 . BACKGROUND: Sirolimus is an immunosuppressive drug recently developed for organ transplantation. Its mechanism of action, independent of calcineurin, is different from that of cyclosporine and tacrolimus, two calcineurin inhibitors (CIs). Because the toxicity of CIs is partly the result of calcineurin blockade, sirolimus exhibits a different toxicity profile. In this study, we evaluated ...
Known for Renal Transplant Recipients | Cutaneous Adverse Events | Receiving Sirolimus | Immunosuppressive Agents Kidney
KOL-Index: 9121 . BACKGROUND: Obesity is more common in adults with psoriasis than in the general population, but there is a lack of data available regarding this association in children. OBJECTIVES: To evaluate whether obesity was more common in French children with psoriasis of any clinical type or severity. METHODS: A multicentre case-control study was performed in 23 French dermatology centres. Children ...
Known for Children Psoriasis | Multicentre Study | Overweight Obesity | Chronic Disease
KOL-Index: 9121 . BACKGROUND: Excessive ultraviolet (UV) radiation exposure can cause skin cancers, skin photoageing and cataracts. Children are targeted by sun-protection campaigns because high sun exposure and sunburn in childhood increase the risk of melanoma in adulthood. Little information is available about UV radiation risk and exposure in children who take part in outdoor sports. OBJECTIVE: To ...
Known for Outdoor Sports | Uv Radiation | Skin Lesions | Sun Exposure
KOL-Index: 8933 . BACKGROUND: Age of the patients and age of onset of psoriasis may have an impact on the disease. There is little information about psoriasis in elderly patients. OBJECTIVE: We evaluated epidemiological, clinical aspects, comorbidities and treatments of psoriasis in the elderly (>70 years) patients, and in patients with very late onset psoriasis (onset ≥ 70 years). METHODS: This ...
Known for Onset Psoriasis | Elderly Patients | Clinical Aspects | Female France
KOL-Index: 8610 . INTRODUCTION: Psoriasis is associated with a higher risk of cardiovascular and/or metabolic comorbidity in adults, but discordant data have been reported in children. OBJECTIVE: To evaluate the frequency of metabolic and cardiovascular comorbidity in children with psoriasis and to establish whether age at onset of psoriasis correlates with metabolic and cardiovascular comorbidity in ...
Known for Children Psoriasis | Obesity Hypertension | Metabolic Comorbidities | Cardiovascular Risk
KOL-Index: 8507 . Association of drug-induced hypersensitivity syndrome with viral infection is debated. Human herpesvirus 6 (HHV-6) reactivation has been the most frequently reported infection associated with this syndrome. However, a case of cytomegalovirus (CMV) infection was recently described associated with anticonvulsant-induced hypersensitivity syndrome. We report a case of severe ...
Known for Hypersensitivity Syndrome | Barr Virus | Ebv Infection | Hhv6 Dna
KOL-Index: 8352 . BACKGROUND/OBJECTIVES: Little information is available on the prevalence and clinical aspects of nail involvement in children with psoriasis. The objective of this study was to evaluate the prevalence and clinical aspects of and the risk factors for nail involvement in French children with psoriasis. METHODS: We performed a multicenter, cross-sectional study in 23 French dermatology ...
Known for Nail Psoriasis | 313 Children | Clinical Aspects | Psoriatic Arthritis
KOL-Index: 8209 . There is a known relationship between the use of immunosuppressive therapies and the development of lymphoproliferative malignancies. These lymphomas are mainly B-cell nonHodgkin's lymphomas associated with Epstein-Barr virus. Most cases concern classical immunosuppressive treatments including ciclosporin and methotrexate. A relationship between the new antitumour necrosis factor ...
Known for Cell Lymphoma | Patients Psoriasis | Immunosuppressive Therapies | Lymphoproliferative Malignancies

Key People For Children Psoriasis

Top KOLs in the world
Amy S Paller
atopic dermatitis pediatric patients epidermolysis bullosa
Matthias Augustin
chronic wounds atopic dermatitis skin diseases
Kristian Reich
plaque psoriasis psoriatic arthritis monoclonal antibodies
Alan M Menter
psoriatic arthritis monoclonal antibodies patients psoriasis
Enno Christophers
atopic dermatitis human skin dermal fibroblasts
Alice Bendix Gottlieb
psoriatic arthritis monoclonal antibodies patients psoriasis

Dermatology Department, Centre Hospitalier (CH), Argenteuil, France | Hôpital Victor Dupouy, Dermatologie, Argenteuil, France | Service de Dermatologie, Hôpital Victor Dupouy, Argenteuil, France | Department of Dermatology, Victor Dupouy Hospital, Ar